These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 12859158

  • 1. Effect of losartan on microalbuminuria in normotensive patients with type 2 diabetes mellitus. A randomized clinical trial.
    Zandbergen AA, Baggen MG, Lamberts SW, Bootsma AH, de Zeeuw D, Ouwendijk RJ.
    Ann Intern Med; 2003 Jul 15; 139(2):90-6. PubMed ID: 12859158
    [Abstract] [Full Text] [Related]

  • 2. Use of losartan in reducing microalbuminuria in normotensive patients with type-2 diabetes mellitus.
    Agha A, Bashir K, Anwar E.
    Nepal Med Coll J; 2007 Jun 15; 9(2):79-83. PubMed ID: 17899953
    [Abstract] [Full Text] [Related]

  • 3. Clinical characteristics of normotensive renal transplant recipients with microalbuminuria and effects of angiotensin II type I receptor antagonist on urinary albumin excretion.
    Satoh S, Horikawa Y, Kakinuma H, Tsuchiya N, Wang L, Kato T, Habuchi T.
    Int J Urol; 2004 Aug 15; 11(8):585-91. PubMed ID: 15285746
    [Abstract] [Full Text] [Related]

  • 4. The IGF-I system and the renal and haemodynamic effects of losartan in normotensive patients with type 2 diabetes mellitus: a randomized clinical trial.
    Zandbergen AA, Lamberts SW, Baggen MG, Janssen JA, Boersma E, Bootsma AH.
    Clin Endocrinol (Oxf); 2006 Feb 15; 64(2):203-8. PubMed ID: 16430721
    [Abstract] [Full Text] [Related]

  • 5. Reduction of microalbuminuria by using losartan in normotensive patients with type 2 diabetes mellitus: A randomized controlled trial.
    Agha A, Amer W, Anwar E, Bashir K.
    Saudi J Kidney Dis Transpl; 2009 May 15; 20(3):429-35. PubMed ID: 19414946
    [Abstract] [Full Text] [Related]

  • 6. Effects of angiotensin II receptor antagonist on endothelial vasomotor function and urinary albumin excretion in type 2 diabetic patients with microalbuminuria.
    Tan KC, Chow WS, Ai VH, Lam KS.
    Diabetes Metab Res Rev; 2002 May 15; 18(1):71-6. PubMed ID: 11921421
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.
    Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M.
    Ann Intern Med; 1993 Apr 15; 118(8):577-81. PubMed ID: 8452322
    [Abstract] [Full Text] [Related]

  • 9. Combination therapy with aliskiren versus ramipril or losartan added to conventional therapy in patients with type 2 diabetes mellitus, uncontrolled hypertension and microalbuminuria.
    Imbalzano E, Scarpelli M, Mandraffino G, Creazzo M, Lizio G, Trapani G, Dattilo G, Dalbeni A, Tomasello C, Sardo MA, Saitta A.
    J Renin Angiotensin Aldosterone Syst; 2015 Dec 15; 16(4):956-64. PubMed ID: 25070350
    [Abstract] [Full Text] [Related]

  • 10. Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trial.
    Ravid M, Brosh D, Levi Z, Bar-Dayan Y, Ravid D, Rachmani R.
    Ann Intern Med; 1998 Jun 15; 128(12 Pt 1):982-8. PubMed ID: 9625684
    [Abstract] [Full Text] [Related]

  • 11. Effects of low-dose losartan treatment on persistent microalbuminuria in normotensive type 1 diabetic subjects.
    Açbay O.
    J Endocrinol Invest; 2001 Sep 15; 24(8):608-11. PubMed ID: 11686543
    [Abstract] [Full Text] [Related]

  • 12. Summaries for patients. The blood pressure drug losartan appears to benefit the kidneys of people with type 2 diabetes who do not have high blood pressure.
    Ann Intern Med; 2003 Jul 15; 139(2):I24. PubMed ID: 12859179
    [No Abstract] [Full Text] [Related]

  • 13. Effect of low-dose ramipril on microalbuminuria in normotensive or mild hypertensive non-insulin-dependent diabetic patients. North-East Italy Microalbuminuria Study Group.
    Trevisan R, Tiengo A.
    Am J Hypertens; 1995 Sep 15; 8(9):876-83. PubMed ID: 8541002
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antihypertensive and anti-albuminuric effects of losartan potassium and felodipine in Chinese elderly hypertensive patients with or without non-insulin-dependent diabetes mellitus.
    Chan JC, Critchley JA, Tomlinson B, Chan TY, Cockram CS.
    Am J Nephrol; 1997 Sep 15; 17(1):72-80. PubMed ID: 9057957
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy of ACE inhibitors and ATII receptor blockers in patients with microalbuminuria: a prospective study.
    Tütüncü NB, Gürlek A, Gedik O.
    Acta Diabetol; 2001 Dec 15; 38(4):157-61. PubMed ID: 11855793
    [Abstract] [Full Text] [Related]

  • 18. Effects of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and their combination on microalbuminuria in normotensive patients with type 2 diabetes.
    Atmaca A, Gedik O.
    Adv Ther; 2006 Dec 15; 23(4):615-22. PubMed ID: 17050503
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial.
    Cherney DZI, Zinman B, Inzucchi SE, Koitka-Weber A, Mattheus M, von Eynatten M, Wanner C.
    Lancet Diabetes Endocrinol; 2017 Aug 15; 5(8):610-621. PubMed ID: 28666775
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.